je.st
news
Tag: street
Street Sweeping FAQs
2015-05-07 00:26:17| PortlandOnline
Questions and answers about PBOT's Street Sweeping Program.
Street Sweeping Map
2015-05-07 00:11:07| PortlandOnline
City crews follow a set of 39 night sweep maps over six districts and 102 day sweep maps across seven districts. Check out this map and enter your address to determine what map and district you are in.
Tags: map
street
sweeping
street map
Oilpatch, Bay Street take stock of NDP election victory in Alberta
2015-05-06 23:38:58| Energy - Topix.net
The new reality of an orange-tinged Alberta was beginning to sink in across the oilpatch and Bay Street on Wednesday and, though there were some jitters, many are awaiting more details before they pass judgment. The NDP's election landslide victory in a province that's been a Progressive Conservative bastion for 44 years stunned Sonny Mottahed, president and CEO of Black Spruce Merchant Capital in Calgary.
Tags: street
stock
bay
election
Oilpatch, Bay Street take stock of NDP election victory in Alberta
2015-05-06 23:29:44| Oil & Gas - Topix.net
The new reality of an orange-tinged Alberta was beginning to sink in across the oilpatch and Bay Street on Wednesday and, though there were some jitters, many are awaiting more details before they pass judgment. The NDP's election landslide victory in a province that's been a Progressive Conservative bastion for 44 years stunned Sonny Mottahed, president and CEO of Black Spruce Merchant Capital in Calgary.
Tags: street
stock
bay
election
The Wall Street Journal: Alexion to buy Synageva in $8.4 billion biotech deal
2015-05-06 13:59:13| Biotech - Topix.net
Alexion Pharmaceuticals Inc. has agreed to buy Synageva BioPharma Corp. in a cash-and-stock deal valued at $8.4 billion, a move that will strengthen Alexion's pipeline of rare-disease treatments. shareholder will receive $115 in cash and 0.6581 Alexion share, for a total consideration of about $225.92 a share based on Alexion's After the deal, Alexion will have eight treatments in clinical trials, including Synageva's experimental enzyme-replacement therapy for patients with mucopolysaccharidosis IIIB, a rare metabolic disease.
Sites : [293] [294] [295] [296] [297] [298] [299] [300] [301] [302] [303] [304] [305] [306] [307] [308] [309] [310] [311] [312] next »